New antibody TSR-022 takes on advanced cancers in first human trial
NCT ID NCT02817633
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study is the first to test TSR-022, an experimental antibody that targets a protein called TIM-3 on immune cells, in people with advanced solid tumors. The trial has two parts: first, finding the safest dose, and second, seeing how well the drug works when given alone or with other cancer treatments. About 463 adults with tumors that have spread or cannot be removed are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Goodyear, Arizona, 85338, United States
-
GSK Investigational Site
Scottsdale, Arizona, 85258, United States
-
GSK Investigational Site
Tucson, Arizona, 85704, United States
-
GSK Investigational Site
Tucson, Arizona, 85711, United States
-
GSK Investigational Site
Encinitas, California, 92024, United States
-
GSK Investigational Site
Fountain Valley, California, 92708, United States
-
GSK Investigational Site
Los Angeles, California, 90024, United States
-
GSK Investigational Site
Los Angeles, California, 90025, United States
-
GSK Investigational Site
San Marcos, California, 92069, United States
-
GSK Investigational Site
Whittier, California, 90606, United States
-
GSK Investigational Site
Aurora, Colorado, 80012, United States
-
GSK Investigational Site
Aurora, Colorado, 80045, United States
-
GSK Investigational Site
Denver, Colorado, 80218, United States
-
GSK Investigational Site
New Haven, Connecticut, 06511, United States
-
GSK Investigational Site
Washington D.C., District of Columbia, 20007, United States
-
GSK Investigational Site
Jacksonville, Florida, 32224, United States
-
GSK Investigational Site
Miami, Florida, 33140, United States
-
GSK Investigational Site
Sarasota, Florida, 34232, United States
-
GSK Investigational Site
Tampa, Florida, 33612, United States
-
GSK Investigational Site
Atlanta, Georgia, 30322, United States
-
GSK Investigational Site
Augusta, Georgia, 30912, United States
-
GSK Investigational Site
Arlington Heights, Illinois, 60005, United States
-
GSK Investigational Site
Chicago, Illinois, 60637, United States
-
GSK Investigational Site
Niles, Illinois, 60714, United States
-
GSK Investigational Site
Iowa City, Iowa, 52242, United States
-
GSK Investigational Site
Wichita, Kansas, 67214, United States
-
GSK Investigational Site
Louisville, Kentucky, 40202, United States
-
GSK Investigational Site
Pikeville, Kentucky, 41501, United States
-
GSK Investigational Site
Wheaton, Maryland, 20850, United States
-
GSK Investigational Site
Boston, Massachusetts, 02114, United States
-
GSK Investigational Site
Detroit, Michigan, 48202, United States
-
GSK Investigational Site
Rochester, Minnesota, 55905, United States
-
GSK Investigational Site
Florissant, Missouri, 63031, United States
-
GSK Investigational Site
St Louis, Missouri, 63110, United States
-
GSK Investigational Site
St Louis, Missouri, 63129, United States
-
GSK Investigational Site
St Louis, Missouri, 63141, United States
-
GSK Investigational Site
Hackensack, New Jersey, 07601, United States
-
GSK Investigational Site
New York, New York, 10016, United States
-
GSK Investigational Site
The Bronx, New York, 10461, United States
-
GSK Investigational Site
Cincinnati, Ohio, 45242, United States
-
GSK Investigational Site
Cleveland, Ohio, 44106, United States
-
GSK Investigational Site
Toledo, Ohio, 43623, United States
-
GSK Investigational Site
Eugene, Oregon, 97401, United States
-
GSK Investigational Site
Vancouver, Oregon, 97213-2982, United States
-
GSK Investigational Site
Bethlehem, Pennsylvania, 18015, United States
-
GSK Investigational Site
Pittsburgh, Pennsylvania, 15232, United States
-
GSK Investigational Site
Charleston, South Carolina, 29425, United States
-
GSK Investigational Site
Greenville, South Carolina, 29605, United States
-
GSK Investigational Site
Nashville, Tennessee, 37203, United States
-
GSK Investigational Site
Austin, Texas, 78705, United States
-
GSK Investigational Site
Dallas, Texas, 75246, United States
-
GSK Investigational Site
Fort Worth, Texas, 76104, United States
-
GSK Investigational Site
Houston, Texas, 77030, United States
-
GSK Investigational Site
Longview, Texas, 75601, United States
-
GSK Investigational Site
McAllen, Texas, 78503-1298, United States
-
GSK Investigational Site
San Antonio, Texas, 78229, United States
-
GSK Investigational Site
Temple, Texas, 76508, United States
-
GSK Investigational Site
Tyler, Texas, 75702, United States
-
GSK Investigational Site
Fairfax, Virginia, 22031, United States
-
GSK Investigational Site
Kennewick, Washington, 99336, United States
-
GSK Investigational Site
Puyallup, Washington, 98373, United States
-
GSK Investigational Site
Seattle, Washington, 98111, United States
-
GSK Investigational Site
Tacoma, Washington, 98405, United States
-
GSK Investigational Site
Madison, Wisconsin, 53792, United States
-
GSK Investigational Site
Daegu, 42601, South Korea
-
GSK Investigational Site
Seoul, 02841, South Korea
-
GSK Investigational Site
Seoul, 03722, South Korea
-
GSK Investigational Site
Seoul, 06351, South Korea
-
GSK Investigational Site
Seoul, 7061, South Korea
-
GSK Investigational Site
Barcelona, 08017, Spain
-
GSK Investigational Site
Barcelona, 08025, Spain
-
GSK Investigational Site
Barcelona, 8035, Spain
-
GSK Investigational Site
Girona, 17007, Spain
-
GSK Investigational Site
Jerez de la Frontera, 11407, Spain
-
GSK Investigational Site
L'Hospitalet de Llobrega, 08908, Spain
-
GSK Investigational Site
Las Palmas de Gran Canar, 35016, Spain
-
GSK Investigational Site
Madrid, 28027, Spain
-
GSK Investigational Site
Madrid, 28040, Spain
-
GSK Investigational Site
Madrid, 28041, Spain
-
GSK Investigational Site
Madrid, 28046, Spain
-
GSK Investigational Site
Madrid, 28222, Spain
-
GSK Investigational Site
Málaga, 29010, Spain
-
GSK Investigational Site
Palma de Mallorca, 07120, Spain
-
GSK Investigational Site
Pamplona, 31008, Spain
-
GSK Investigational Site
Santander, 39008, Spain
-
GSK Investigational Site
Seville, 41013, Spain
-
GSK Investigational Site
Valencia, 46010, Spain
-
GSK Investigational Site
Valencia, 46026, Spain
-
GSK Investigational Site
Zaragoza, 50009, Spain
Conditions
Explore the condition pages connected to this study.